A research team has demonstrated that clopidogrel is more effective than aspirin as a long-term antiplatelet therapy in ...
Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...
A growing body of evidence shows that heart attacks can occur even when angiograms look normal. Cardiologists explain MINOCA, ...
Women’s cardiovascular health has long been overlooked and understudied. Here are some things to keep in mind.
1 Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Department of Cardiology, Ministry of Education, First Affiliated Hospital of Gannan Medical University, ...
ADT speeds coronary atherosclerosis, with greater effects with use of the GnRH-agonist leuprolide compared with the GnRH-antagonist relugolix. Coronary atherosclerosis may progress more over 12 months ...
Reduced coronary blood flow, measured with an artificial intelligence-based imaging tool, predicted future cardiovascular events in patients with suspected stable coronary artery disease. These ...
Watch: Shubman Gill walking out of Woodlands hospital after neck spasms treatment Originally posted on CricketGully | Last updated Nov 17, 2025 12:03 AM ET Indian Test captain Shubman Gill has been a ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Coronary artery disease (CAD) is the most prevalent form of ...
1 Department of Cardiology, Shenzhen Nanshan People’s Hospital, Shenzhen, China 2 Department of Intensive Care, Shenzhen Nanshan People’s Hospital, Shenzhen, China Background: Coronary artery spasm ...
Patients benefit from antiplatelet therapy after coronary-artery bypass grafting (CABG) for an acute coronary syndrome. Whether the addition of ticagrelor to aspirin, as compared with aspirin alone, ...
In patients with multilayer in-stent restenosis (ISR), treatment with a paclitaxel-coated balloon reduced target lesion failure (TLF) at 1 year to 23.8% compared with 40% with an uncoated balloon. The ...